For Immediate Release
August 24, 2007

BUFFALO, NY—Roswell Park Cancer Institute (RPCI) will host the National Comprehensive Cancer Network’s (NCCN) Clinical Practice Guidelines in Oncology Symposium on Non-Small Cell Lung Cancer, September 17, 7:30 am – 12:30 pm, in the Zebro Conference Room, Center for Genetics & Pharmacology, Virginia Street.

The conference will offer insights into the NCCN Non-Small Cell Lung Cancer Guidelines to physicians, nurses, pharmacists and other clinical professionals who manage lung cancer patients. The focus will be on sequential recommendations for the management of lung malignancies; examine new treatment approaches that have been incorporated into the guidelines including the use of drugs, biologics and diagnostics. The conference will feature interactive audience participation using case scenarios to discuss the application of guidelines and the data supporting specific recommendations.

RPCI faculty presenters are Alex A. Adjei, MD, PhD, Senior Vice President of Clinical Research and the Katherine Anne Gioia Chair in Cancer Medicine, who will discuss “Novel Agents for the Therapy of Lung Cancer,” and Todd L. Demmy, MD, Chief of Thoracic Surgery who will present “Therapy for Stages I, IIA, IIB, and IIIA (T3, N1) Non-Small Cell Lung Cancer.”

Additional topics and presenters are:

• “NCCN Guidelines Overview” − Joan S. McClure, MS, National Comprehensive Cancer Network
• “Workup, Prognosis Factors, and Markers” – Cory J. Langer, MD, Fox Chase Cancer Center
• “Treatment Options for Unresectable Stage III Non-Small Cell Lung Cancer” – David S. Ettinger, MD, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
• “Neoadjuvant Combined Modality Therapy for Potentially Resectable Stage III Non-Small Cell Lung Cancer” – Mark G. Kris, MD, Memorial Sloan-Kettering Cancer Center
• “Management of Metastatic Non-Small Cell Lung Cancer” – Gregory A. Otterson, MD, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at the Ohio State University

For more information or to register for the program, visit the NCCN website at www.nccn.org or call 1-866-788-NCCN.

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. The primary goal of all NCCN initiatives is to improve the quality, effectiveness and efficiency of oncology practices so patients can live better lives.

Roswell Park Cancer Institute, founded in 1898, is the nation’s first cancer research, treatment and education center and is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. RPCI is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers. Roswell Park has affiliate sites and collaborative programs in New York, Pennsylvania, and in China. For more information, visit RPCI’s website at http://www.roswellpark.org, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail http://askrpci@roswellpark.org.

 

-30-